4.1 Article

Symptoms and treatment of bipolar patients in Sweden

Journal

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/13651501.2011.653377

Keywords

Bipolar disorder; symptoms; rating scale; prediction

Categories

Funding

  1. Stockholm County Council (ALF) [20060306, 20080247]
  2. Soderstrom-Konigska Foundation
  3. Bristol-Myers Squibb
  4. Organon
  5. Pfizer
  6. Janssen-Cilag
  7. AstraZeneca
  8. Eli Lilly
  9. Sanofi-Aventis

Ask authors/readers for more resources

Objective. The objective of the study was to investigate affective symptoms and pharmacological treatment in bipolar I disorder patients, and to test whether self-rated symptoms could predict hospital admissions during a 12-month follow-up period. Methods. A total of 231 outpatients with clinical bipolar I disorder were recruited. The clinical diagnoses were reassessed by a semi-structured interview. Twenty-four patients (10%) was reclassified as bipolar disorder type II or schizoaffective disorder (bipolar type). Medication status was recorded and symptoms were assessed with the self-rating scale AS-18. Patients were prospectively followed for 12 months and hospitalizations during that time were recorded. Results. More than half (60%) rated themselves as normothymic. Mixed affective symptoms were more common than either depressive or manic/hypomanic symptoms. The admission rate during 1 year of follow-up was 13% (95% C.I.8-17%). Patients which at baseline rated themselves high in either mania or in depression had a significantly increased risk for hospitalization (OR = 3.15; 95% C. I. 1.38-7.19). Conclusions. The findings should encourage clinicians to use patient self ratings in order to identify patients with a high risk for hospitalization for targeted interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available